Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by barack

T.PHO

Are these guys big?

http://www.dorigo.com/industries/case-studies/11-industries/87-how-to-deliver...

December 10, 2014

T.PHO

Be nice to get a larger slice of this pie

http://www.marketsandmarkets.com/PressReleases/smart-sensor.asp

December 10, 2014

ESPAF

RE:RE:RE:Sold 100

I'm in SEV and VXS too. Small caps have been taking it in the chin...

December 4, 2014

T.PHO

RE:RE:RE:RE:RE:Technically entering oversold

Most funds will not buy a TSX venture stock. Every stock I own have quarterly...

December 3, 2014

V.SEV

RE:Oculus Grows Up

http://www.cnbc.com/id/102233074

December 3, 2014

T.GUD

RE:RE:news

Spam??

December 2, 2014

ESPAF

RE:Sold 100

100 lots or 100 shares?

December 2, 2014

T.PHO

RE:RE:RE:Technically entering oversold

PHO went up 1000% because it was ridiculously oversold in the first place...

December 2, 2014

T.PHO

RE:Technically entering oversold

It will be always oversold due to lack of market interest. This's what...

December 2, 2014

T.GUD

news

http://www.newswire.ca/en/story/1456663/crh-medical-announces-significant...

December 2, 2014

T.VXS

This might mean one less competitor for VIXS products

Refocused Strategy and Restructuring Plan Entropic also announced its...

December 2, 2014

V.POI.H

RE:RE:Buy on the Dips

Nice technology but can someoe explain to me why SLC should have a $100...

November 28, 2014

T.PHO

RE:RE:Impressive

Photon is up from all time lows where it was priced for failure. It should...

November 27, 2014

T.PHO

RE:RE:RE:RE:RE:RE:RE:RE:RE:Sp malaise

Hey Rose I'm with you that the CEO doesn't want to communicate how...

November 25, 2014

T.PHO

RE:pho vs phm

Very difficult to compare pho and phm in terms of market and business model...

November 21, 2014

T.VNP

RE:RE:RE:Enjoy the roller coster ride (and play it as such) !

If you bought at $1.50 and didn't take profits at $4 plus that would suck...

November 14, 2014

T.VNP

RE:Enjoy the roller coster ride (and play it as such) !

Have to admit defeat on this one. The numbers seem cheap, but the market...

November 13, 2014

ESPAF

RE:RE:Could we have been wrong re the unnamed NA tier1 customer?

http://www.theglobeandmail.com/report-on-business/bell-strikes-distribution...

November 13, 2014

ESPAF

RE:Could we have been wrong re the unnamed NA tier1 customer?

It would take us to another level if it is Shomi (Shaw - Rogers) really...

November 13, 2014

ESPAF

RE:Could we have been wrong re the unnamed NA tier1 customer?

http://www.cnbc.com/id/102181131?trknav=homestack:topnews:14

November 13, 2014

Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »